Regulation of eukaryotic gene expression frequently is achieved at the level of transcription via the interaction of specific proteins with sequence elements located within the promoter region (Maniatis et al. 1987) . Quantitative and/or qualitative changes in specific DNAbinding proteins can positively or negatively modulate the temporal and spatial pattern of gene expression during maturation of the organism. The expression of the 5S ribosomal RNA genes during the development of the South African clawed toad, Xenopus laevis, has been characterized extensively (Engelke et al. 1980; Korn 1982; Shastry et al. 1982; Wormington et al. 1982 )and provides a model system for the analysis of developmental control at the level of transcription. The primary step required for expression of the 5S genes in Xenopus is the binding of a positively acting gene-specific transcription factor, TFIIIA, to the internal control region of the 5S gene (Bogenhagen et al. 1980; Engelke et al. 1980; Bieker and Roeder 1984) . TFIUA binding permits the subsequent formation of a transcription complex involving at least two other transcription factors, TFIIIB and TFIIIC, and RNA polymerase IU (Lassar et al. 1983; Bieker et al. 1985) . TFIIIA was the first eukaryotic transcription factor that was purified to homogeneity and for which a cDNA was isolated and the corresponding primary amino acid sequence obtained (Ginsberg et al. 1984) . On the basis of this sequence, Miller et al. (1985) proposed a TFIIIA structure with several zinc-binding 'fingers' which are involved in DNA binding. This structure has since been identified in other DNA binding proteins (Kadonaga et al. 1988) .
The TFIIIA protein serves a dual role in 5S gene expression, acting both as a 5S gene-specific transcriptional activator (Engelke et al. 1980) and as a specific RNA-binding protein that interacts with 5S RNA to form the 7S ribonucleoprotein storage particle (Honda and Roeder 1980; Pelham and Brown 1980) . During the development of X. laevis, a distinct pattern of expression of two classes of 5S RNA genes is observed: whereas the somatic 5S gene family is expressed in both oocytes and somatic cells, expression of the oocyte 5S genes decreases dramatically following oogenesis. Although the differential regulation of the two 5S gene classes involves several control mechanisms (Andrews and Brown 1987; Wolffe and Brown 1987, 1988) , the demonstration that TFIIIA is required for transcription of both 5S gene families (Engelke et al. 1980) suggests that an alteration in the level or the activity of TFIIIA may play an important role in the regulation of 5S gene expression during development.
The expression of the TFIIIA gene in Xenopus has also been shown to be under developmental control. Both TFIIIA protein and steady-state mRNA levels are highest in early oogenesis, decrease significantly in later-stage oocytes, and are reduced drastically during embryogenesis and in somatic cells. Thus, TFIUA protein levels are reduced from 1012 to 10 a molecules per cell, whereas RNA levels are reduced from 106 to < 1 molecules per cell during development (Ginsberg et al. 1984; Shastry et al. 1984; Taylor et al. 1986 ). The high levels of TFIIIA protein in oogenesis appear necessary to ensure full activation of both the oocyte type and the somatic type 5S genes as well as stabilization of the RNA product, whereas the low level in somatic cells may be in part responsible for the restriction of activation to somatic genes. An understanding of the mechanism by which TFIIIA gene expression is regulated during Xenopus development would provide insight into an apparent hierarchical network of developmental control in which a gene that encodes a transcriptional regulatory factor is itself regulated in a developmental fashion.
To investigate the process of TFIIIA gene regulation during Xenopus development, we have analyzed the transcription of this gene in oocytes. In this paper we describe the isolation and characterization of a TFIIIA genomic DNA clone and the identification of cis-acting promoter sequences that act both positively and negatively to affect expression of the TFIIIA gene in Xenopus oocytes. Furthermore, using gel retardation assays, we identify DNA-binding proteins that interact with these cis-acting sequences, and we discuss how they may interact to modulate the expression of TFIIIA during development.
Results

Isolation and characterization of TFIIIA genomic clones
A X. laevis genomic library was screened using the TFIIIA cDNA clone, 3al.b, as probe (Ginsberg et al. 1984) . A homologous clone containing the 5' end of the cDNA probe was isolated and characterized further. A gross restriction map of this clone is depicted in Figure  1A . While generally in agreement with the TFIIIA allele described by Tso et al. (1986) , restriction analysis of this gene indicates the presence of at least one additional EcoRI site. The 5' end of the mRNA was mapped within a 2.2-kb genomic EcoRI-PstI fragment by primer extension analysis and the region from position -425 (relative to the transcription start site) through the first exon was sequenced (Fig. 1B) . This gene lacks the PstI site within the first exon, which is present in the allele described previously by Taylor et al. (1986) and displays heterogeneity in the 5' leader sequence when compared to the allele described by Tso et al. (1986) . A consensus TATA sequence is found at position -32 and a putative CAAT box homology begins at position -94.
Positive and negative cis-acting dements are involved in TFIIIA gene expression in oocytes
We have begun an analysis of the nature and location of the 5'-flanking sequences that are involved in the transcription of this gene following microinjection into X. laevis oocytes (stages V and VI). To facilitate later analysis, we replaced most of the body of the TFIIIA gene with a fragment derived from the human f~-globin gene (Poncz et al. 1983 ). The chimeric constructs contain a transcription start site derived from the TFIIIA gene in addition to a part of the second and the third exon of the ~-globin gene, including an intron and a functional polyadenylation signal (Fig. 1C) .
A set of sequential exonuclease Bal31-generated 5' deletions was constructed within the TFIIIA promoter region; the exact end point of each deletion was determined by DNA sequencing (Fig. 1D) . Deletion mutants, along with a marked X. laevis histone H4 gene, were analyzed following coinjection into stage V and VI oocytes. Primer extension of a properly initiated TFIIIA transcript generates a fragment 109 nucleotides in length while the extension product for the H4 control gene is 181-187 nucleotides in length. The result of a typical analysis is shown in Figure 2A . Figure 2B shows the level of transcription of each deletion mutant relative to the level observed for the H4 control gene. Each number represents the average of a minimum of four independent experiments. In general, the same pattern of expression was seen whether low (400 pg) or high (2 ng) concentrations of DNA were injected.
Comparison of the level of expression directed by the -1500 and -306 constructs indicates that sequences downstream of -306 are adequate for efficient expression of the TFIIIA gene, although the possibility of other functional elements occurring upstream of -306 is not necessarily excluded. Deletion of sequences downstream from -306 revealed several major cis-acting elements in addition to the TATA box. Thus, removal of sequences between position -306 and -300 resulted in a substantial increase in transcription from the mutant promoter, indicating the presence of an element which has a negative influence on transcription. Deletion to -289, -267, and -265 progressively decreased transcription to the level observed with the wild-type (-1500) promoter. Further deletion through -253 to -235 decreased transcription still further (to about 25% of control levels). These results indicate the presence of one or more positive cis-acting elements within these regions. It should be noted that in several independent experiments, the -175 deletion mutant promoted a somewhat higher level of transcription than did the -235 mutant, suggesting the presence of another negative element. The -148, -76, and -49 deletion mutants directed approximately the same low level of expression; therefore, in the absence of upstream sequence elements, elimination of the putative CAAT box at position -94 by 5' deletion had no significant effect on transcription. Deletion of the TATA box at position -32 abolishes transcription from the TFIIIA promoter.
To investigate further the region downstream of the cis-acting elements between -306 and -235, as well as to identify potential cis-acting elements whose function is dependent on the presence of upstream sequences, several internal deletion mutants were constructed using the -306 TFUIA promoter mutant as a template. Some portion of the deleted sequence was replaced with linker sequence. Analysis of these mutants by microinjection both confirmed and extended the conclusions drawn from the 5' deletion studies (Fig. 3) . Of the nine internal deletion mutants (IDM)examined, IDM 4 ( -1 8 1 / -1 7 3 deletion), IDM 7 ( -7 5 / -5 8 deletion), and IDM 8 ( -6 4 / -4 8 deletion)promoted the same level of expression as the -3 0 6 deletion mutant, which will be considered wild type in describing the following analyses. Therefore, internal deletion of sequences between -181 and -173 and between -75 and -4 8 did not affect transcription of the microinjected gene. However, IDM 2 ( -2 2 3 / -1 7 3 deletion) and IDM 3 ( -2 1 4 / -1 7 3 deletion) were transcribed at only 49% and 53% of the wild-type levels, respectively, whereas IDM 1 ( -2 5 0 / -226 deletion)reduced transcription to 17%. Taken together, these data define at least one cis-acting element lying between -2 5 0 and -1 7 3 within the TFIIIA promoter. Deletion of the region from -144/-101 (IDM 5) reduced transcription to 42%, suggesting the presence of yet another positive-acting element within this region.
Removal of intemal sequences containing the CAAT box (IDM 6, -9 3 / -7 8 ) r e d u c e d transcription approximately twofold, whereas deletion of the region containing the TATA box (IDM 9, -3 8 / -4 ) abolished transcription.
Identification of protein factors that bind within the TFIIIA promoter
Because much of the expression of the TFIIIA gene in stage V and VI oocytes was dependent on sequences within the region spanning -3 0 6 to -175, we attempted to identify by gel retardation assays any oocyte proteins that bind within this region. A double-stranded promoter fragment that included sequences from -3 0 6 to -180 was labeled and incubated with a crude cellular extract prepared from a whole Xenopus ovary containing oocytes representing all six stages of oogenesis. Following electrophoresis on a 6% native acrylamide gel, two retarded complexes, designated B 1 and B2, could be identified (Fig. 4) . To prove that the association of these proteins within the TFIIIA promoter was sequence specific and to delimit the regions in which they bind, we tested the ability of various DNA fragments derived from deletion mutants of the TFIIIA promoter to compete for these interactions. A fragment containing promoter sequences extending from -2 8 9 to + 88 was able to compete for binding of the proteins complexed in both B1 and B2. However, similar fragments with 5' end points at -265, -253, and -2 3 5 were able to compete only for the B2 complex. The -175 and -148 deletion fragments were unable to compete for either complex. Additional assays using double-stranded oligonucleotides as competitors (Fig. 5A, B) showed strong competition for the B1 complex with sequences spanning positions -2 8 9 to -2 5 2 and -271 to -2 5 2 and less competion with an oligonucleotide spanning -3 0 6 to -265. The B2 complex was competed with an oligonucleotide containing sequences from -2 5 2 to -221. An oligonucleotide spanning positions -2 2 0 to -180 did not compete for either complex. These results indicate that the binding site for the protein involved in the formation of the B1 complex includes the region between -271 and -2 6 5 , and that sequences between -2 6 5 and -2 5 2 stabilize this interaction. The binding site for the B2 complex lies downstream of -2 3 5 and is disrupted or eliminated by removal of sequences between -2 3 5 and -221.
The B1 binding site shares homology with the consensus sequence for the adenovirus major late transcription factor, USF
Analysis of the nucleotide sequence in the region involved in the formation of the B1 complex revealed a partial homology ( -2 6 9 5'-CACGTG-3' -264) to the binding sequence for the adenovirus major late transcription factor, USF (Carthew, et al. 1985; Sawadogo and Roeder 1985) . Preincubation with an oligonucleotide containing the human USF consensus binding site, 5'-GGCCACGTGACC-3', inhibited formation of the B 1 complex, indicating that this sequence is indeed involved in the binding of the B1 protein(s). Competition with a nonspecific oligonucleotide containing an octamer transcription factor -1 binding site (Fletcher et al. 1987 ) had no effect on the formation of the complex Figure 4 . Detection of two prominent DNA binding complexes in X. laevis whole ovary extracts. A a2P-labeled probe spanning the TFIIIA promoter region from -306 to -180 was incubated with 30 ~g of whole ovary extract in the standard gel electrophoresis DNA binding assay. Two complexes, designated B 1 and B2, could be resolved on a 6% polyacrylamide gel.
Competitor fragments (100 ng; 25-to 50-fold molar excess} were isolated from TFIIIA 5' deletion mutants and included sequences from the position indicated at the top of each lane through + 88.
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free Figure 5 . {A) Double-stranded oligonucleotides used as competitors in gel shift analysis. Position within the TFIIIA promoter is shown above each sequence. BamHI restriction sites flank each oligonucleotide. (B) The TFIIIA promoter fragment from -306 to -180 was incubated with 30 ~g of whole ovary extract under standard gel shift conditions. Competitor oligonucleotides {200 ng){500-to 1500-fold molar excess)were added as designated above each lane.
{Fig. 6A). To substantiate further the relationship between the Xenopus B1 complex protein(s) and human USF, a partially purified preparation of USF {the kind gift from M. Sawadogo, Rockefeller University, New York} was substituted for the oocyte extract in a gel shift assay {Fig. 6B). Clearly, the human USF bound to the TFIIIA promoter, generating the two retarded complexes characteristic of the binding of USF to the major late promoter (Sawadogo 1988; Sawadogo et al. 1988} . The shifted bands have approximately the same Rf value as does the B1 complex {data not shown).
The region between -235 and -221 (5'-AGGG-GAGTGTCCAGA-3'), within which the B2 protein binds, contains a 9-out of 12-bp homology {bases underlined} to the consensus binding sequence for the NF~J3 protein (5'-GGGGACTTTCCG-3') (Sen and Baltimore 1986) . However, no competition for B2 complex formation was observed in gel shift analyses with oligonucleotides containing the NFKB consensus sequence, the related binding sequence for the ubiquitous transcription factor H2TF1 {5'-GGGGATTCCCC-3'){Baldwin and Sharp 1987}, or the immunoglobulin heavy-chain NTF protein {5'-GGGGGAGGTTCC-3'){B. Yoza and R.G. Roeder, in prep.}. Furthermore, purified NFvJ3 protein (the kind gift of K. Kawakami, Rockefeller University, New York; Kawakami et al. 1988} did not bind within the B2 region {data not shown}.
Point mutations affect binding of B1 and B2 proteins as well as efficiency of transcription of microinjected constructs
To delineate further the sequences required for formation of the B 1 and B2 complexes, as well as to verify the requirement for these sequences in the efficient expression of the TFIIIA promoter in vivo, point mutations were made within the binding regions delimited by the gel shift analyses. In the two mutants analyzed, the 5' end point was at position -306. The B 1 promoter mutation is shown in Figure 7A . Microinjection analyses showed that this mutant promoted 45% of the expression of the wild-type -3 0 6 promoter {Fig. 7B). Gel shift analyses using this mutant promoter as competitor showed that although it can compete for binding of the oocyte protein{s) to the wild-type promoter fragment, it does so with a five-to sevenfold reduced efficiency {Fig.
8n).
The B2 box point mutant {Fig. 7A)was transcribed in oocytes with approximately twofold lower efficiency than the -3 0 6 promoter {Fig. 7B). When used as a competitor in gel shift analyses, the B2 mutant promoter was found to compete three-to fivefold less well than the wild-type promoter for the B2 complex {Fig. 8B).
D i s c u s s i o n
The regulation of transcription in eukaryotic cells involves the interaction of protein factors with specific DNA promoter sequences. To understand the role that these protein-DNA interactions play in the modulation of gene expression, it is necessary to determine how the expression of the genes encoding transcription factors is regulated. Because the 5S gene-specific transcription factor TFIIIA is both regulated developmentally and one of the first eukaryotic factors for which the corre-
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GENES & DEVELOPMENT sponding gene has been isolated, it provides an ideal system in which to examine the next level in the hierarchy of transcriptional control. We have defined several elements that are involved in the expression of this gene in late stage oocytes, and have identified two protein factors, potentially important for activation, which bind within these sequences.
TFIIIA alleles exhibit polymorphism, yet are highly conserved throughout the promoter region
Tso et al. {1986} have described previously allelic differences among cloned TFIIIA cDNA and genomic DNA sequences based in part on the presence or absence of a PstI site at position 139 within the protein coding sequence. On the basis of this criterion, the gene described in this report most closely resembles the allele described by Taylor et al. {1986}, which lacks a PstI site at position 139. On a gross level, our data further substantiate the proposed allelic heterogeneity, as we have observed differences in at least one additional restriction site between the two genes described. Nucleotide sequence analysis revealed further heterogeneity within the 5' leader sequence; within 50 bp there are five nucleotide differences between the two alleles.
One negative and three positive cis-acting elements have been defined within the TFIIIA promoter
A functional analysis of the region between -3 0 6 and -1 7 3 has implicated at least three distinct and closely spaced sequence elements in the expression of the TFIIIA gene in X. laevis oocytes. A negative element lies between -3 0 6 and -289, whereas a positive element lies directly downstream of the negative element and involves sequences from position -2 8 9 to -253. Intemal deletions and point mutations in the regions between -250 and -173 and between -144 and -101 reduce transcriptional efficiency, indicating the presence of additional positive-acting elements within these regions. That these latter elements were only detected in analysis of internal deletions or point mutants suggests that upstream promoter regions not present in the 5' deletion mutants may be required for their activity. We cannot ignore the possibility, however, that effects of intemal deletions that have not yet been confirmed by point mutations may result from changes in spacing generated by the deletions. Although removal of the putative CAAT box by 5' deletion had no appreciable effect on transcription, an intemal deletion mutant in which sequences between -9 3 and -78, including the CAAT sequence, were removed supported 49% of wild-type expression; whether this decrease is due to removal of the CAAT box or an adjacent element is presently under investigation. Removal of sequences between -4 7 and -11 abolishes transcription from the TFIIIA promoter. Because the TATA box is found within this region, we assume that most if not all of this effect results from its removal. Recently, Matsumoto and Kom (1988) TFIIIA promoter lying between -2 8 3 / -2 3 8 and -167/-122; the location of the three positive elements defined in our analyses agrees with and extends their observations. A summary of the cis-acting elements within the TFIILA promoter is depicted in Figure 9 .
Two oocyte proteins bind within elements required for the efficient expression of the TFIIIA promoter in oocytes
To define the nature and function of the proteins interacting within the TFIIIA promoter, we have used gel shift assays to identify sequence-specific DNA binding proteins present in X. laevis oocyte extracts. To date, we have resolved two DNA-protein complexes, designated B1 and B2, which involve a promoter fragment containing sequences from -3 0 6 to -180. We have shown by competition analysis that the binding of the protein(s) involved in the B1 complex requires sequences between -2 8 9 and -2 5 2 , a region that is shown to be involved in the activation of this gene in oocytes. Similar analysis of the B2 complex has allowed us to map the binding site for this protein between -235 and -221 within the TFIIIA promoter, a region contained within a second activator element located between -2 5 0 and -173. Therefore, sequences shown to be required for the in vivo expression of the TFIIIA gene bind proteins, which we assume act as regulators of TFIIIA gene expression.
The protein(s) involved in the formation of the B1 complex is related to the major late transcription factor, USF
It has recently become apparent that, in addition to eukaryotic RNA polymerases (Sentenac 1985} , several eukaryotic transcription factors have been highly conserved during evolution {Buratowski et al. 1988}. Several mammalian factors have been shown to have homologous counterparts in Xenopus. The Xenopus cytoskeletal actin gene contains a 20-bp homology to the human c-los serum response element that binds a Xenopus factor homologous to the human serum response factor (Mohun et al. 1987) . Doebbeling et al. (1988) have identified a cell-specific activator region within the Xenopus A2 vitellogenin gene that is active transcriptionally in rat liver nuclear extracts. A Xenopus histone H4 transcription factor, XH4TF1, is most likely homologous to the human histone H4 transcription factor H4TF2 (G.H. Thomsen and R.G. Roeder, in prep.I. Emerson and Roeder [1984) have shown that Xenopus and human RNA polymerase III factors are interchangable in functional assays. The relationship we have identified between the Xenopus B 1 protein and the human major late transcription factor extends these observations. The major late transcription factor, USF (Sawadogo and Roeder 1985} or MLTF (Carthew et al. 19851 was identified initially by its ability to bind selectively to and activate transcription from the adenovirus major late promoter. More recently, it has been found to bind to and activate cellular genes, such as the rat 7-fibrinogen promoter ) and the mouse metallothionein I gene promoter (Carthew et al. 19871. USF-related proteins also have been reported in yeast (Bram and Komberg 1987) . We have found that the X. laevis oocyte protein involved in the formation of the B 1 complex is similar in size and binding properties to the human USF protein, binding to a 6-bp core CACGTG of the 12-bp adenovirus major late sequence; the resulting complex migrates with a similar Rf value as does the complex formed between the Xenopus-DNA fragment and the human USF protein [data not shown}. Recently, it has been demonstrated that polyclonal mouse antibodies raised against human USF interact with the B1 complex in a gel shift assay, resulting in a second shift with lower electrophoretic mobility (H. Kaulen, unpubl.) . Whether the Xenopus protein is functionally similar to the human protein awaits purification and in vitro analysis. However, the location of its binding site over 260 bp upstream of the start site of transcription suggests that if its function involves interaction with TFIID, as has been suggested for the major late USF (Sawadogo and Roeder 1985}, bending This model is similar to the mechanism described for regulation of the B-interferon gene, in which a negative regulatory element in proximity to a constitutive transcriptional element binds a factor that is released on induction (Goodbourn et al. 1986; Zinn and Maniatis 1986) . We are continuing our search for trans-acting factors involved in the expression of this gene and will determine whether the modulation of these proteins throughout oogenesis, embryogenesis, and in somatic cells is involved in the regulation of the TFIIIA gene.
Materials and methods
Cloning and characterization of the TFIIIA gene
A Xenopus genomic library constructed in EMBL4 using partial Sau3A-digested high-molecular-weight DNA was the kind gift of D. Melton (Harvard University). The library was screened with the TFIIIA eDNA 3al.b (Ginsberg et al. 1984 )using standard techniques (Maniatis et al. 1982) . Two clones were analyzed further and the TFIIIA transcription unit contained 
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Cold Spring Harbor Laboratory Press on January 18, 2018 -Published by genesdev.cshlp.org Downloaded from therein was oriented relative to subclones of the 3al.b cDNA. Previous primer extension analysis (Ginsberg et al. 1984) allowed us to map the 5' end of the cDNA within a genomic 2.2 kb EcoRI-PstI fragment, which was subcloned into pUC 12 or 13, or M13mp8 or M13mpg, prior to nucleotide sequencing. Unless otherwise noted, all restriction enzymes used for these and subsequent analyses were obtained from either New England Biolabs, Bethesda Research Laboratories, or BoehringerMannheim Biochemicals, and reactions were carried out according to suppliers' specifications.
Construction of 5' deletion mutant chimeric genes
The pUC 13 plasmid containing the 2.2-kb EcoRI-PstI fragment was linearized by digestion with BgllI. Sequential deletions were generated using the exonuclease Ba131 and conditions recommended by the vendor (IBI). Following digestion, the ends were repaired with the Klenow fragment of DNA polymerase I and EcoRI linkers were added at the deletion end points. EcoRI-RsaI fragments extending from the 5' deletion end point through 88 bp of the first TFIIIA exon were sized by gel electrophoresis, isolated, and subcloned into EcoRI-SmaIdigested pUC 13. The end points of the 5' deletion mutants were determined in a sequencing reaction using the chain-termination method and Sequenase reagents (U.S. Biochemical Corp.).
TFIIIA/~-globin chimeric genes were constructed by joining each promoter deletion mutant to a 1689-bp BamHI-PstI fragment derived from the human f~-globin gene {Poncz et al. 1983) containing part of the second and all of the third exon of the ~-globin gene, including the second intervening sequence and a polyadenylation signal.
Cloning of the internal deletion mutants
The 3' promoter deletion mutants were constructed following the same general strategy as described above. A pUC 13 plasmid containing 306 bp of the TFIIIA promoter region was digested with BamHI and treated with Bal31 exonuclease {IBI). BamHI linkers were ligated to the truncated 3' ends of the TFIIIA promoter. EcoRI-BamHI fragments of varying size were isolated and subcloned into EcoRI-BamHI-digested pUC 13.
Suitable 5' and 3' promoter mutants in pUG 13 were chosen for cloning of the internal deletion mutants. The 3' mutants were digested with BamHI, and the 5' overhanging ends were filled in with DNA polymerase I Klenow fragment and recut with HindIII, a polylinker restriction site close to the BamHI site. The 5' deletions were digested with EcoRI, filled in, and redigested with HindIII. The EcoRI-HindIIl fragments were gel-purified and ligated to the 3' mutants prepared as described. All internal deletion mutants were confirmed by sequence analysis. For IDM 2, IDM 3, and IDM 4, the deletion end points were separated by a 14-bp synthetic linker, (5'-CGGGAT-CAATTCCT-3'). IDM 5 contains a 19-bp insertion (5'-CGGGATCAATTCCACAGGC-3'); 13 bp were provided by a synthetic linker and 6 bp are due to a rearrangement at the target sequence during cloning. IDM 6, IDM 7, IDM 8, and IDM 9 contain a 13-bp synthetic linker sequence {5'-CGGGAT-CAATTCC-3'). In some cases, the inserted sequence restored the original promoter sequence, which was taken into account when calculating the spacing change.
Site-directed mutagenesis
The point mutants in the B1 and B2 boxes and IDM 1 were constructed using the site-directed mutagenesis protocol of Kunkel et al. (1987) , with minor modifications. A TFIIIA promoter fragment including sequences from -306 to + 88 was subcloned into the vector pEMBL19, which contains an fl origin of replication and can be used to generate single-stranded templates (Dente et al. 1985) . The recombinant plasmid was transformed into the Escherichia coli dut-ung-strain BW313 {Kunkel 1985). Following superinfection with fl phage, singlestranded DNA was purified for use in subsequent mutagenesis procedures. The oligonucleotides used to produce the B1 box mutation contained the sequence -280 5'-TCATGTAT-TATCTCGAGCTCGACTAGGAC-3' -252; the B2 box mutant oligonucleotide included the sequence -253 5'-ACT-3' -214 (altered bases are underlined). The internal deletion IDM 1 {-250 to -226)was created using oligonucleotides flanking the deletion site. Sequenase (U.S. Biochemical Corp.) replaced T4 DNA polymerase in the in vitro synthesis reactions. Mutations were verified by nucleotide sequencing.
Microinjection experiments in stage V and V/X. laevis oocytes
Ovaries were obtained from large adult female X. laevis purchased from either Nasco (Fort Atkinson, Wisconsin) or Xenopus (Michigan). Individual stage V and VI oocytes (staged according to Dumont 1972) were teased from the ovary and stored in MSB-H buffer [88 mM NaC1, 1 rnM KC1, 2.4 mM NaHCOa, 0.82 mM MgS04, 0.33 ~ Ca{NO3)2, 0.41 mM CaC12, 10 mM HEPES (pH 7.6), 10 mg/ml of penicillin, 10 mg/ml of streptomycin] for several hours up to 4 days prior to use. Subsequent microinjections and incubations were performed in MSB-H buffer. For each TFIIIA promoter mutant analyzed, a X. laevis histone H4 gene, into which a 9-bp HindIII linker was inserted for identification (G. Thompsen, Rockefeller University, New York) was coinjected as a control; 400 pg or 2 ng of both the control and mutant plasmid DNA in 10 nl or 40 nl of H20, respectively, were injected into the germinal vesicles of 25-50 oocytes. Injected oocytes were incubated for 20 hr at 230C, then harvested for further analysis.
Isolation of RNA from microinjected oocytes
Surviving oocytes (75-100%)were collected, pooled, and washed several times in TE buffer [10 mM Tris (pH 8.0), 1 rnM EDTA], then homogenized in an extraction buffer containing 10 mM Tris {pH 7.6), 10 rnM NAG1, 10 mM EDTA, 0.5% SDS, and 0.14 mg/ml Proteinase K and incubated for 1 hr at 37°C. Following incubations, samples were brought to 0.3 M sodium acetate and extracted several times with phenol, phenol/chloroform, and chloroform. The RNA was precipitated, recovered by centrifugation, and resuspended in 10 ~1 of H20 per oocyte equivalent prior to quantitation. Between 3 and 5 ~g of total RNA was recovered per oocyte. RNA integrity was monitored by agarose gel electrophoresis prior to analysis.
Primer extension experiments
Primer extension analyses were performed in primer excess, using 1.5 oocyte equivalents of total RNA for analysis of TFIIIA gene expression (5-7 ~g), and 0.5 oocyte equivalents of RNA for analysis of transcription of the control H4 gene {1.5-2.5 ~g), and 3 ng{ 1 x l0 s to 2 x l0 s cpm) of the appropriate primers. Synthetic oligonucleotides corresponding to a region of exon 2 of the human 13-globin gene and spanning a synthetic modification introduced in the histone H4 gene were radioactively labeled with T4 polynucleotide kinase and [~/-a2p]ATP. Neither primer was found to cross-hybridize to any endogenous oocyte Cold Spring Harbor Laboratory Press on January 18, 2018 -Published by genesdev.cshlp.org Downloaded from
